Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mayatepek

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Journal of Inherited Metabolic Disease|January 1, 1994
SSIEM Award. Impaired metabolism of leukotrienes in inherited metabolic disordersE Mayatepek, G F Hoffmann
European Journal of Pediatrics|November 19, 1997
Persistent hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical outcome and mutational analysisT Meissner, W Brune, E Mayatepek
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 1999
Sensitivity of electrospray-tandem mass spectrometry using the phenylalanine/tyrosine-ratio for differential diagnosis of hyperphenylalaninemia in neonatesA Schulze, D Kohlmueller, E Mayatepek
Mediators of Inflammation|January 1, 1993
Enhanced levels of leukotriene B(4) in synovial fluid in Lyme diseaseE Mayatepek, D Hassler, M Maiwald
The Journal of Pediatrics|July 11, 2001
Long-term clinical outcome in patients with glutathione synthetase deficiencyE Ristoff, E Mayatepek, A Larsson
Biology of the Neonate|January 1, 1991
Severe intrauterine infection due to Capnocytophaga ochraceaE Mayatepek, E Zilow, S Pohl
Journal of Inherited Metabolic Disease|July 13, 2004
Acute metabolic crisis with extreme deficiency of glutathione in combination with decreased levels of leukotriene C4 in a patient with glutathione synthetase deficiencyE Mayatepek, T Meissner, H Gröbe
Human Mutation|May 25, 1999
Congenital hyperinsulinism: molecular basis of a heterogeneous diseaseT Meissner, B Beinbrech, E Mayatepek
Advances in Enzyme Regulation|January 1, 1993
Peroxisomal leukotriene degradation: biochemical and clinical implicationsG Jedlitschky, E Mayatepek, D Keppler
Neuropediatrics|January 22, 2003
White matter disease in cerebral organic acid disorders: clinical implications and suggested pathomechanismsS Kölker, E Mayatepek, G F Hoffmann
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Journal of Inherited Metabolic Disease|January 1, 1994
SSIEM Award. Impaired metabolism of leukotrienes in inherited metabolic disordersE Mayatepek, G F Hoffmann
European Journal of Pediatrics|November 19, 1997
Persistent hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical outcome and mutational analysisT Meissner, W Brune, E Mayatepek
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 1999
Sensitivity of electrospray-tandem mass spectrometry using the phenylalanine/tyrosine-ratio for differential diagnosis of hyperphenylalaninemia in neonatesA Schulze, D Kohlmueller, E Mayatepek
Mediators of Inflammation|January 1, 1993
Enhanced levels of leukotriene B(4) in synovial fluid in Lyme diseaseE Mayatepek, D Hassler, M Maiwald
The Journal of Pediatrics|July 11, 2001
Long-term clinical outcome in patients with glutathione synthetase deficiencyE Ristoff, E Mayatepek, A Larsson
Biology of the Neonate|January 1, 1991
Severe intrauterine infection due to Capnocytophaga ochraceaE Mayatepek, E Zilow, S Pohl
Journal of Inherited Metabolic Disease|July 13, 2004
Acute metabolic crisis with extreme deficiency of glutathione in combination with decreased levels of leukotriene C4 in a patient with glutathione synthetase deficiencyE Mayatepek, T Meissner, H Gröbe
Human Mutation|May 25, 1999
Congenital hyperinsulinism: molecular basis of a heterogeneous diseaseT Meissner, B Beinbrech, E Mayatepek
Advances in Enzyme Regulation|January 1, 1993
Peroxisomal leukotriene degradation: biochemical and clinical implicationsG Jedlitschky, E Mayatepek, D Keppler
Neuropediatrics|January 22, 2003
White matter disease in cerebral organic acid disorders: clinical implications and suggested pathomechanismsS Kölker, E Mayatepek, G F Hoffmann
Pageof 18